Galilee Energy secures additional leases for Zydeco Gas Project
Galilee Energy (ASX:GLL) has secured additional mineral leases for its Zydeco Gas Project in Louisiana, USA.
Galilee Energy (ASX:GLL) has secured additional mineral leases for its Zydeco Gas Project in Louisiana, USA.
Macquarie Group (ASX:MQG) has poached Westpac (ASX:WBC) treasurer Jo Dawson for the equivalent role, marking another high-profile move in an intensifying talent shake-up across Australia's major banks.
High-Tech Metals (ASX:HTM) is targeting a potential Wagtail-style gold discovery at its untested Bullock prospect while accelerating financial and development studies to fast-track near-term production at its Wagtail and Damsel deposits.
RareX (ASX:REE) has been granted a mining lease (M80/648) for its 100% owned Cummins Range Project in Western Australia.
Singular Health (ASX:SHG) has announced that the US Food and Drug Administration has granted 510(k) clearance for 3DICOM MD Cloud, the company's cloud-based evolution of its FDA-cleared 3DICOM MD software.
Catalina Resources (ASX:CTN) has moved to strengthen its portfolio with the acquisition of 100% of the Breakaway Dam Copper Project.
L1 Group (ASX:L1G) reported total assets under management of $17.64 billion as of Dec. 31, 2025, up from $16.95 billion at Sept. 30, 2025.
New Age Exploration (ASX:NAE) has resumed reverse circulation drilling at its Wagyu Gold Project in the Pilbara, following a scheduled break over the Christmas and New Year period.
Perth-based mineral exploration company McLaren Minerals (ASX:MML) has released the results of its pre-feasibility study for the 100%-owned McLaren Titanium Project.
Enlitic (ASX:ENL) has completed technical validation of its Ensight medical imaging data standardisation platform on Oracle Cloud Infrastructure, leveraging AMD EPYC processors.
Horizon Oil (ASX:HZN) announced that the Nam Phong joint venture has reached a final investment decision for the Nam Phong Booster Compressor Project.
NeuroScientific Biopharmaceuticals (ASX:NSB) has announced encouraging results from its Special Access Program for patients with fistulising Crohn's disease.